1 / 83

KEY CONCEPTS IN ACUTE PAIN MANAGEMENT - 1 SURGERY RESIDENTS Dec. 18, 2007

KEY CONCEPTS IN ACUTE PAIN MANAGEMENT - 1 SURGERY RESIDENTS Dec. 18, 2007. John Penning MD FRCPC Director Acute Pain Service. Objectives. General Key Concepts The “real cost” of acute pain Multi-modal analgesia Discuss key concepts of each modality

Download Presentation

KEY CONCEPTS IN ACUTE PAIN MANAGEMENT - 1 SURGERY RESIDENTS Dec. 18, 2007

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. KEY CONCEPTS IN ACUTE PAIN MANAGEMENT - 1SURGERY RESIDENTS Dec. 18, 2007 John Penning MD FRCPC Director Acute Pain Service

  2. Objectives • General Key Concepts • The “real cost” of acute pain • Multi-modal analgesia • Discuss key concepts of each modality • COX-inhibitor as foundational analgesic • Coxibs – “platelet sparing” cox-inhibitors • Tylenol # 3 has it’s limitations • Opioids – think outside the “box” • Tramacet – a “me too” drug? Or something to new to add?

  3. Consequences of poorly managed acute post-operative pain • The Patient suffers • CVS: MI, dysrhythmias • Resp: atelectasis, pneumonia • GI: ileus, anastamosis failure • Endocrine: “stress hormones” • Hypercoagulable state: DVT, PE • Impaired immunological state • Infection, cancer, wound healing • Psychological: • Anxiety, Depression, Fatigue • Chronic Post-surgery/trauma Pain

  4. Consequences of poorly managed acute post-operative pain • The Hospital • Increased costs $$$ • Poor staff morale • Reputation/Standing in the Community, Nationally • Accreditation • Litigation • The Healthcare professional • Morale • Complaints to College • Litigation

  5. Benefits of Optimal Acute Post-Operative Pain Management • The Hospital • Increased patient satisfaction • Increased staff morale • Compliance with national guidelines, accreditation criteria • Cost Savings • Earlier ambulation and enteral feeding • Decreased complications/ICU expenditures • Decreased Length of Stay

  6. The New Challenges in Managing Acute Pain after Surgery and Trauma • Patients/Society more “aware” of their rights to have good pain control • We are being held accountable • Pressure from hospital to minimize length of stay • Control pain, limit S/E and complications

  7. The New Challenges in Managing Acute Pain after Surgery and Trauma • The Opioid Tolerant Patient • The greatest change in practice/attitudes in the last 10 years is the now wide spread acceptance of the use of opioids for CHRONIC NON-MALIGNANT PAIN • Renders the “usual” standard “box” orders totally inadequate in these patients • Get an accurate Drug History • The Brief Pain Inventory – “BPI”

  8. What is the “Best Way” to manage acute post-operative pain? • FIRST, DO NO HARM Therefore, the “best way” is a BALANCE Effective Analgesic Modalities Patient Safety

  9. KEY POINTS • “Emphasis is placed on the utilization of a multimodal analgesic approach to maximize analgesia while minimizing side-effects.” • Transduction • Transmission • Modulation • Perception • There is as of yet no single silver bullet!!

  10. Pain Pathways

  11. Acute Pain Management Modalities • Cyclo-oxygenase inhibitors • Non-specific COX inhibitors(classical NSAIDs) • Selective COX-2 inhibitors, the “coxibs” • Acetaminophen is probably COX-3 • Local anesthetics • Opioids • NMDA antagonists • Ketamine, dextromethorphan • Anti-convulsants • Gabapentin, Pregabalin

  12. Tissue Trauma Cell Membrane Phospholipids Phospholipase Arachidonic Acid COX Cyclo-oxygenase Endoperoxides Toxic Oxygen Radicals Thromboxane Prostacyclin Prostaglandins

  13. Analgesia with Opioids alone • The harder we “push” with single mode analgesia, the greater the degree of side-effects Side-effects Analgesia

  14. Multi-modal Analgesia • “With the multimodal analgesic approach there is additive or even synergistic analgesia, while the side-effects profiles are different and of small degree.” Side-effects Analgesia

  15. Case Problem: Severe Respiratory Depression after Toradol? • Healthy 34 yr. patient c/o severe incisional pain in PACU after ovarian cystecomy • Received 200 g fentanyl with induction and 10 mg morphine during case • PCA morphine started in PACU, plus nurse supplements totaled 26 mg in 90 minutes • Still c/o pain, 30 mg Toradol IM given with some relief after 15 minutes, so patient sent to ward • 60 minutes later found unresponsive, cyanotic, RR 4/min.

  16. Case Problem: Severe Respiratory Depression after Toradol? • Pharmacodynamic drug interaction between morphine and NSAID • morphine’s respiratory depressant effect opposed by the stimulatory effects of pain, busy PACU environment • NSAID decreases pain, morphine’s effect unappossed • Gain control of acute pain with fast onset, short acting opioid(fentanyl) • Add NSAID adjunct early • Monitor closely for sedation and respiratory depression after pain isalleviated by any means

  17. The problem with the “Little Pain – LittleGun”, “Big Pain – Big Gun” Approach • With opioids analgesic efficacy is limited by side-effects • “Optimal” analgesia is often difficult to titrate • 10 – fold variability in opioid dose:response for analgesia • A dose of opioid that is inadequate for patient A can lead to significant S/E or even death in patient B. • Many patient factors add to the difficulty • Opioid tolerance, anxiety, obstructive sleep apnea, sleep deprivation, concomitantly administered sedative drugs

  18. The rationale for COX-Inhibitors in acute pain management • The problem with the “Little Pain – Little Gun, Big Pain – Big Gun Approach” • Patient Safety!! If the “Big Gun” is failing due to dose limiting sedation/respiratory depression, the addition at that time of the “Little Gun” may kill the patient.

  19. NSAID and Acetaminophen CONCEPT # 1 The foundation of all acute pain Rx protocols. ”First on last off” • sole agent in mild /moderate pain • Analgesic efficacy is limited inherently • In contrast, with opioids efficacy is limited by S/E • Opioids added as required • opioid sparing effect 30-60 %

  20. Mortality From NSAID-Induced GI Complications vs Other Diseases in US Wolfe MM: NEJM 1999; 340: 1888-99

  21. Penning’s Pessimistic Policy on Pain Pills • Pick your “Poison” Pursuant to Patient Profile • COX-inhibitors are potential killers “in the long run” • Opioids are potential killers “in the short run”

  22. Cyclo-oxygenase inhibitors Acetaminophen Naproxen Celecoxib Ketorolac Rofecoxib

  23. Cell Membrane Phospholipids Phospholipase Arachidonic Acid COX-2 COX-1 Prostaglandins Prostaglandins Acute Pain Gastric Protection Inflammation Platelet Hemostasis Fever

  24. Why a COX-2 inhibitor? • Equivalent analgesic efficacy with non-selective COX-inhibitors • No effects on platelets! • Better GI tolerability • Less dyspepsia, less N/V

  25. Two hours before surgery associated with post-op pain • Celecoxib 400 mg PO If severe allergy to sulfa? • Naproxen 500 mg PO Contra-indications to NSAID Acetaminophen 1000 mg PO

  26. Contra-indications to Celecoxib/NSAIDs • Patients with the “ASA triad” • Risk of severe asthma, angioedema precipitated with COX-inhibitor • Renal insufficiency or risk there of • especially if risk of hypovolemia periop • Vascular patients having aortic cross-clamp and/or probable angiogram peri-operatively • Poorly controlled hypertension • Especially if pt. is on ACE inhibitor, potent loop diuretics

  27. Contra-indications to Celecoxib/NSAIDs • Congestive heart failure • Active peptic ulcer disease • Risk of non-union in bone surgery or non-fusion in spine surgery • COX-1 proven a problem in high doses • COX-2? Proven OK for 5 days

  28. Celecoxib and “sulfa allergy” • Allergy to sulfa?? History, Please! • Most allergies are bogus: N/V, diarrhea • A rash with sulfonamide anti-biotics? Celecoxib belongs to the “other” class of sulfonamides: furosemide, glyberide, etc. • Do not use celecoxib is history of anaphylaxis or severe cutaneous reaction (Steven-Johnson sydrome. etc.) with a sulfonamide

  29. The Opioids • We have to stop trying to put every patient in the “analgesic dose box” Meperidine 75 mg IM Q4H prn Tylenol #3 1 – 2 PO Q4H prn

  30. Opioids CONCEPT # 2 Pharmacokinetic + Pharmacodynamic patient to patient variability results in 1000% variability in opioid dose requirements (standardized procedure, opioid naïve patient) • opioid dosage must be individualized • therefore, if parenteral therapy indicated, IV PCA much better suited to individual patient needs than IM/SC

  31. Opioids *Cancer Pain Monograph (H&W, 1984) CONCEPT # 3 Under utilization of high efficacy PO opioids • PO opioid equivalence of 10 mg morphine IM/SC * Morphine 20 mgmeperidine 200 mg Hydromorphone 4 mgcodeine 200 mg oxycodone 10 mg

  32. True or False? • One opioid is just like any other, in terms of analgesic efficacy and side-effects.

  33. Opioids – Are they all the same? • Morphine • Hydromorphone (dilaudid) • Fentanyl • Oxycodone (parenteral n/a) • Meperidine (demerol)

  34. Opioids – Do they all act the same? • Opioids work as analgesics by activating endogenous inhibitory pain modulating systems • Opioid receptors • Mu, Delta and Kappa • Large genetic variability in expression • Good choice in one patient may be poor choice in another • Analgesic efficacy • Side-effect profile

  35. Meperidine Morphine Atropine Fentanyl Bupivacaine

  36. True or False? • One opioid is just like any other, in terms of analgesic efficacy and side-effects. • Answer. There is considerable variability between patients in response to different opioids.

  37. True or False? • Meperidine should be eliminated from the hospital formulary?

  38. Meperidine Pharmacology • Opioid agonist – Mu and some kappa • NMDA antagonist (weak) • Local anesthetic action – equipotent to lidocaine • SSRI (weak) • Muscaric blockade – “atropine-like” • Central anti-cholinergic effects often causes confusion in the elderly

  39. Meperidine’s major problem • Normeperidine • The “ugly” metabolite • Neuroexcitatory: twitches, dilated pupils, hallucinations, hyperactive DTR, seizures • Non-opioid receptor mediated, no tolerance • Half-life is 15 – 20 hours N-demethylation

  40. Meperidine and MAO Inhibitors • Meperidine blocks the neuronal re-uptake of serotonin, may result in serotonergic crisis in patients being treated with MAO inhibitors • Excitatory reaction with delirium, hyper or hypo tension, hyperthermia, rigidity, seizures, coma, death • Supportive management, ? Benzos, dopaminergics?

  41. When to use Meperidine? • As a third line opioid when other choices have failed • Especially if patient has Hx of such • Less than 600 mg per day • Short duration of 2 days or less • Avoid in elderly or renal failure patients • May be useful in small IV doses to supplement other opioids • 25 mg IV Q1H prn

  42. Who still uses Tylenol # 3 ? • WHY ??

  43. Opioid Myths that still prevail! • Codeine is a “weak” opioid? • Codeine is inherently safer than the more potent opioids?

  44. CODEINE – A drug whose time has come and gone? N Engl J Med 351; 27 Dec. 30, 2004

  45. Problems with Codeine • 62 yr. male with CLL, presents with bilateral pneumonia. • Broncho-lavage revealed yeast • Anti-biotics: Ceftriaxone, clarithromycin, voriconazole • Codeine 25 mg PO TID for cough

  46. Problems with Codeine • Day 4 became markedly sedated, pin-point pupils and ABG reveals PaCO2 of 80 mmHg. Marked improvement with Naloxone. • What’s the expected morphine blood level? • Answer: 1 to 4 mcg/L • This patient’s morphine blood level? • 80 mcg/L

  47. Codeine Metabolism in Normal Circumstances • The major pathways convert codeine to inactive metabolites • CYP3A4 pathway yields norcodeine • Glucuronidation • The minor pathway, about 10%, yields morphine • CYP2D6, essential for analgesic effect 60 mg Codeine PO – approx. 4 mg morphine SC • Variability! 60 mg PO Codeine yields potentially 0 to 60 mg parenteral morphine

More Related